RIPK1 is involved in the pathogenesis of multiple sclerosis, and inhibition of RIPK1 improves experimental autoimmune encephalomyelitis, an animal model of inflammation of the brain and spinal cord27. The gene discussed is RIPK1; the disease is experimental autoimmune encephalomyelitis.